Companies: 10,795·Total market cap: $144.5T
Korro Bio, Inc.

Korro Bio, Inc.

KRRONASDAQHealthcare● Active
$10.59
$-0.13(-1.21%)
Market Cap$105406157
P/E Ratio
52W High$55.89
52W Low$5.204

Korro Bio, Inc. (KRRO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

krro · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 12 Wall Street analysts in the past 3 months

SellBuy

Buy

12 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
10
Hold
2
Sell
0
Strong Sell
0
Total: 12 · Buy rate: 83.3%

12-Month Price Target

High

$30.00

Consensus

$19.57

+84.8% upside

Low

$10.00

Median: $22 · Last Close: $10.59

The Korro Bio, Inc. (KRRO) analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month KRRO price target is $19.57, representing +84.8% upside from the current price of $10.59.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $20 (84.8%)

Consensus Target

$19.57

84.8% upside

High Target

$30

183.3%

Low Target

$10

-5.6%

Current Price

$10.59

as of today

Based on analyst price targets, the KRRO stock price prediction for the next 12 months ranges from $10 to $30. The consensus KRRO price forecast of $19.57 implies 84.8% upside from the current price of $10.59.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$10.292.87%

1-day model range: $10.17–$10.4. Peak: $10.4 (-2.87%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$7-34.2%
2028$6-45.4%
2029$5-50.1%
2030$5-52.2%
2031-53.3%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)53.5Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · KRRO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$10.91SELL
MA 10$12.04SELL
MA 20$11.37SELL
MA 50$12.39SELL
MA 100$11.90SELL
MA 200$18.12SELL
Current $KRRO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$11.08SELL
EMA 10$11.42SELL
EMA 20$11.67SELL
EMA 50$12.00SELL
EMA 100$12.84SELL
EMA 200$16.35SELL
Current $KRRO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-05-19
Maintains
BuyBuy
Cantor Fitzgerald2026-03-13
Maintains
OverweightOverweight
Raymond James2026-03-13
Upgrade ↑
Market PerformOutperform
Clear Street2026-02-19
Upgrade ↑
HoldBuy
William Blair2026-02-17
Upgrade ↑
Market PerformOutperform
Piper Sandler2026-01-29
Upgrade ↑
NeutralOverweight
Chardan Capital2026-01-29
Upgrade ↑
NeutralBuy
HC Wainwright & Co.2026-01-29
Upgrade ↑
NeutralBuy
Oppenheimer2026-01-28
Upgrade ↑
PerformOutperform
Cantor Fitzgerald2026-01-28
Upgrade ↑
NeutralOverweight

Wall Street analysts have recently issued updated ratings on Korro Bio, Inc. (KRRO) stock. Of the recent 43 rating actions, 8 were upgrades and 6 were downgrades. 12 analysts currently cover KRRO.

Analyst Recommendation Trends

Buy ratings312
Hold ratings00
Sell ratings00

KRRO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$2M

↑ 24.2% YoY

Revenue Next Year

$1M

↓ 41.9% YoY

EPS This Year

$-5.32

EPS Next Year

$-5.13

↓ 3.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast KRRO EPS of $-5.32 for the current fiscal year, based on estimates from 9 analysts. The KRRO revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The KRRO stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus KRRO price target is $19.57 (+84.8% upside), with an analyst consensus of Buy.

The KRRO short-term stock prediction for tomorrow is $10.29 (-2.87%). The KRRO stock price prediction for 2027 estimates an average of $7. The KRRO stock prediction for 2030 projects a range of $4–$6.

Korro Bio, Inc. trades on NASDAQ under the ticker KRRO. The KRRO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 83% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

KRRO forecast · 8 questions

According to 12 Wall Street analysts, the average 12-month KRRO price target is $19.57, with a high forecast of $30.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +84.8% potential upside from the current price of $10.59.

KRRO price targetWhat is KRRO price targetKRRO analyst price targetKRRO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.